BRIGHTSPRING HEALTH SERVICES (BTSG) Fundamental Analysis & Valuation

NASDAQ:BTSG • US10950A1060

Current stock price

41.21 USD
-2.78 (-6.32%)
At close:
41.36 USD
+0.15 (+0.36%)
After Hours:

This BTSG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BTSG Profitability Analysis

1.1 Basic Checks

  • BTSG had positive earnings in the past year.
  • BTSG had a positive operating cash flow in the past year.
  • In multiple years BTSG reported negative net income over the last 5 years.
  • BTSG had a positive operating cash flow in 4 of the past 5 years.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

1.2 Ratios

  • BTSG has a Return On Assets of 2.97%. This is in the better half of the industry: BTSG outperforms 62.38% of its industry peers.
  • BTSG has a Return On Equity of 10.17%. This is in the better half of the industry: BTSG outperforms 70.30% of its industry peers.
  • The Return On Invested Capital of BTSG (4.92%) is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for BTSG is significantly below the industry average of 8.94%.
  • The last Return On Invested Capital (4.92%) for BTSG is above the 3 year average (3.12%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.97%
ROE 10.17%
ROIC 4.92%
ROA(3y)-0.04%
ROA(5y)-0.04%
ROE(3y)-5.79%
ROE(5y)-3.62%
ROIC(3y)3.12%
ROIC(5y)3.41%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

1.3 Margins

  • With a decent Profit Margin value of 1.48%, BTSG is doing good in the industry, outperforming 61.39% of the companies in the same industry.
  • BTSG's Profit Margin has improved in the last couple of years.
  • BTSG has a Operating Margin (2.29%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BTSG has declined.
  • The Gross Margin of BTSG (11.76%) is worse than 69.31% of its industry peers.
  • BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.29%
PM (TTM) 1.48%
GM 11.76%
OM growth 3Y-8.26%
OM growth 5Y-5.03%
PM growth 3YN/A
PM growth 5Y31.69%
GM growth 3Y-12.49%
GM growth 5Y-8.96%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. BTSG Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BTSG is destroying value.
  • The number of shares outstanding for BTSG has been increased compared to 1 year ago.
  • Compared to 5 years ago, BTSG has more shares outstanding
  • Compared to 1 year ago, BTSG has an improved debt to assets ratio.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.47 indicates that BTSG is not in any danger for bankruptcy at the moment.
  • BTSG's Altman-Z score of 3.47 is fine compared to the rest of the industry. BTSG outperforms 73.27% of its industry peers.
  • The Debt to FCF ratio of BTSG is 6.41, which is on the high side as it means it would take BTSG, 6.41 years of fcf income to pay off all of its debts.
  • BTSG has a Debt to FCF ratio of 6.41. This is comparable to the rest of the industry: BTSG outperforms 54.46% of its industry peers.
  • A Debt/Equity ratio of 1.32 is on the high side and indicates that BTSG has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.32, BTSG is not doing good in the industry: 66.34% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.41
Altman-Z 3.47
ROIC/WACC0.58
WACC8.51%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • BTSG has a Current Ratio of 1.57. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSG has a Current ratio of 1.57. This is in the better half of the industry: BTSG outperforms 62.38% of its industry peers.
  • BTSG has a Quick Ratio of 1.12. This is a normal value and indicates that BTSG is financially healthy and should not expect problems in meeting its short term obligations.
  • BTSG has a Quick ratio (1.12) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.12
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. BTSG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 105.45% over the past year.
  • Measured over the past years, BTSG shows a very strong growth in Earnings Per Share. The EPS has been growing by 48.27% on average per year.
  • BTSG shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.59%.
  • Measured over the past years, BTSG shows a quite strong growth in Revenue. The Revenue has been growing by 18.27% on average per year.
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5Y48.27%
EPS Q2Q%50%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y18.69%
Revenue growth 5Y18.27%
Sales Q2Q%16.31%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.03% on average over the next years. This is a very strong growth
  • BTSG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.97% yearly.
EPS Next Y22.73%
EPS Next 2Y23.46%
EPS Next 3Y24.02%
EPS Next 5Y36.03%
Revenue Next Year15.67%
Revenue Next 2Y13.91%
Revenue Next 3Y15.99%
Revenue Next 5Y16.97%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

2

4. BTSG Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 36.47, BTSG can be considered very expensive at the moment.
  • BTSG's Price/Earnings ratio is in line with the industry average.
  • BTSG is valuated rather expensively when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 29.72, which means the current valuation is very expensive for BTSG.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BTSG.
  • BTSG's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 36.47
Fwd PE 29.72
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BTSG is on the same level as its industry peers.
  • BTSG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 20.21
EV/EBITDA 23.83
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • BTSG's earnings are expected to grow with 24.02% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.6
PEG (5Y)0.76
EPS Next 2Y23.46%
EPS Next 3Y24.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BTSG Dividend Analysis

5.1 Amount

  • No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BTSG Fundamentals: All Metrics, Ratios and Statistics

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (3/20/2026, 8:00:02 PM)

After market: 41.36 +0.15 (+0.36%)

41.21

-2.78 (-6.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners83.46%
Inst Owner Change-7.04%
Ins Owners2.45%
Ins Owner Change5.38%
Market Cap7.93B
Revenue(TTM)12.91B
Net Income(TTM)190.67M
Analysts86.36
Price Target45.36 (10.07%)
Short Float %5.75%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.02%
Min EPS beat(2)-7.56%
Max EPS beat(2)41.61%
EPS beat(4)3
Avg EPS beat(4)39.33%
Min EPS beat(4)-7.56%
Max EPS beat(4)97.01%
EPS beat(8)4
Avg EPS beat(8)19.15%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.92%
Max Revenue beat(2)3.22%
Revenue beat(4)4
Avg Revenue beat(4)3.06%
Min Revenue beat(4)2.86%
Max Revenue beat(4)3.24%
Revenue beat(8)7
Avg Revenue beat(8)3.51%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.14%
PT rev (3m)10.32%
EPS NQ rev (1m)13.42%
EPS NQ rev (3m)11.96%
EPS NY rev (1m)1.22%
EPS NY rev (3m)1.76%
Revenue NQ rev (1m)1.86%
Revenue NQ rev (3m)3.3%
Revenue NY rev (1m)0.74%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 36.47
Fwd PE 29.72
P/S 0.62
P/FCF 20.21
P/OCF 16.27
P/B 4.25
P/tB N/A
EV/EBITDA 23.83
EPS(TTM)1.13
EY2.74%
EPS(NY)1.39
Fwd EY3.37%
FCF(TTM)2.04
FCFY4.95%
OCF(TTM)2.53
OCFY6.15%
SpS66.71
BVpS9.69
TBVpS-6.35
PEG (NY)1.6
PEG (5Y)0.76
Graham Number15.69
Profitability
Industry RankSector Rank
ROA 2.97%
ROE 10.17%
ROCE 6.47%
ROIC 4.92%
ROICexc 5.01%
ROICexgc 16.35%
OM 2.29%
PM (TTM) 1.48%
GM 11.76%
FCFM 3.06%
ROA(3y)-0.04%
ROA(5y)-0.04%
ROE(3y)-5.79%
ROE(5y)-3.62%
ROIC(3y)3.12%
ROIC(5y)3.41%
ROICexc(3y)3.16%
ROICexc(5y)3.45%
ROICexgc(3y)13.08%
ROICexgc(5y)15.96%
ROCE(3y)4.1%
ROCE(5y)4.49%
ROICexgc growth 3Y-3.92%
ROICexgc growth 5Y0.08%
ROICexc growth 3Y9.04%
ROICexc growth 5Y7.15%
OM growth 3Y-8.26%
OM growth 5Y-5.03%
PM growth 3YN/A
PM growth 5Y31.69%
GM growth 3Y-12.49%
GM growth 5Y-8.96%
F-Score8
Asset Turnover2.01
Health
Industry RankSector Rank
Debt/Equity 1.32
Debt/FCF 6.41
Debt/EBITDA 5.37
Cap/Depr 58.12%
Cap/Sales 0.74%
Interest Coverage 1.61
Cash Conversion 106.64%
Profit Quality 207%
Current Ratio 1.57
Quick Ratio 1.12
Altman-Z 3.47
F-Score8
WACC8.51%
ROIC/WACC0.58
Cap/Depr(3y)44.68%
Cap/Depr(5y)39.63%
Cap/Sales(3y)0.79%
Cap/Sales(5y)0.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.45%
EPS 3YN/A
EPS 5Y48.27%
EPS Q2Q%50%
EPS Next Y22.73%
EPS Next 2Y23.46%
EPS Next 3Y24.02%
EPS Next 5Y36.03%
Revenue 1Y (TTM)14.59%
Revenue growth 3Y18.69%
Revenue growth 5Y18.27%
Sales Q2Q%16.31%
Revenue Next Year15.67%
Revenue Next 2Y13.91%
Revenue Next 3Y15.99%
Revenue Next 5Y16.97%
EBIT growth 1Y43.11%
EBIT growth 3Y8.89%
EBIT growth 5Y12.32%
EBIT Next Year72.82%
EBIT Next 3Y31.89%
EBIT Next 5Y29.67%
FCF growth 1Y790.75%
FCF growth 3YN/A
FCF growth 5Y18.25%
OCF growth 1Y1961.79%
OCF growth 3YN/A
OCF growth 5Y17.1%

BRIGHTSPRING HEALTH SERVICES / BTSG Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a fundamental rating of 4 / 10 to BTSG.


Can you provide the valuation status for BRIGHTSPRING HEALTH SERVICES?

ChartMill assigns a valuation rating of 2 / 10 to BRIGHTSPRING HEALTH SERVICES (BTSG). This can be considered as Overvalued.


How profitable is BRIGHTSPRING HEALTH SERVICES (BTSG) stock?

BRIGHTSPRING HEALTH SERVICES (BTSG) has a profitability rating of 4 / 10.


What is the financial health of BRIGHTSPRING HEALTH SERVICES (BTSG) stock?

The financial health rating of BRIGHTSPRING HEALTH SERVICES (BTSG) is 4 / 10.


What is the earnings growth outlook for BRIGHTSPRING HEALTH SERVICES?

The Earnings per Share (EPS) of BRIGHTSPRING HEALTH SERVICES (BTSG) is expected to grow by 22.73% in the next year.